Recent Progress and Challenges in the Development of Antisense Therapies for Myotonic Dystrophy Type 1

por De Serres-Bérard, Thiéry, Ait Benichou, Siham, Jauvin, Dominic, Boutjdir, Mohamed, Puymirat, Jack, Chahine, Mohamed
Publicado 2022

Antisense oligonucleotides as a potential treatment for brain deficits observed in myotonic dystrophy type 1

por Ait Benichou, Siham, Jauvin, Dominic, De Serres-Bérard, Thiéry, Pierre, Marion, Ling, Karen K., Bennett, C. Frank, Rigo, Frank, Gourdon, Genevieve, Chahine, Mohamed, Puymirat, Jack
Publicado 2022